Toll-Like Receptors in Acute Kidney Injury

Autor: Sandra Rayego-Mateos, Mercedes Vallejo-Mudarra, Isabel Cortegano, María Luisa Gaspar, Carmen Herencia-Bellido, Lucas Opazo-Ríos, Melania Guerrero-Hue, Cristina Vázquez-Carballo, José Luis Morgado-Pascual, Cristina García-Caballero, Juan Antonio Moreno, Belén de Andrés, Jesús Egido
Přispěvatelé: [Vázquez-Carballo,C, Rayego-Mateos,S, Opazo-Ríos,L, Herencia-Bellido,C, Egido,J] Renal, Vascular and Diabetes Research Laboratory, IIS-Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Madrid, Spain. [Guerrero-Hue,M, García-Caballero,C, Morgado-Pascual,JL, Vallejo-Mudarra,M, Moreno,JA] Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Hospital Universitario Reina Sofía, Córdoba, Spain. [Opazo-Ríos,L, Egido,J] Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), Madrid, Spain. [Cortegano,I, Gaspar,ML, de Andrés,B] Immunobiology Department, Carlos III Health Institute, Majadahonda (Madrid), Spain. [Moreno,JA] Biomedical Research Networking Center on Cardiovascular Diseases (CIBERCV), Madrid, Spain. [Moreno,JA] Department of Cell Biology, Physiology and Immunology, University of Cordoba, Cordoba, Spain, The authors work has been supported by grants from Instituto de Salud Carlos III (ISCIII, FIS-FEDER PI17/00130, PI17/01495, PI20/00375, PI20/00487), Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM) and Cardiovascular (CIBERCV), Spanish Ministry of Science and Innovation (RTI2018-099114-B-100, RTI2018-098788-B-100, DTS19/00093, RYC-2017-22369), and Spanish Societies of Cardiology (SEC), Nephrology (SEN) and Atherosclerosis (SEA). The 'PFIS' and 'Sara Borrell' training program of the ISCIII supported the salary of MGH (FI18/00310), SR-M (CD19/00021) and CH-B (CP16/00017). Córdoba University supported the salary of C.G.C. No other relevant affiliations or financial involvement exist with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties., Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación (España), Sociedad Española de Cardiología, Sociedad Española de Nefrología, Sociedad Española de Arteriosclerosis, University of Córdoba (España), UAM. Departamento de Farmacología, UAM. Departamento de Medicina, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Universidad de Córdoba
Jazyk: angličtina
Rok vydání: 2021
Předmět:
0301 basic medicine
Chemicals and Drugs::Amino Acids
Peptides
and Proteins::Proteins::Membrane Proteins::Receptors
Cell Surface::Receptors
Immunologic::Receptors
Pattern Recognition::Toll-Like Receptors::Toll-Like Receptor 4 [Medical Subject Headings]

Anatomy::Urogenital System::Urinary Tract::Kidney [Medical Subject Headings]
Nefrología y urología
medicine.medical_treatment
Diseases::Male Urogenital Diseases::Urologic Diseases::Kidney Diseases::Renal Insufficiency::Acute Kidney Injury [Medical Subject Headings]
Review
Bioinformatics
urologic and male genital diseases
Kidney
drugs
Analytical
Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Probability::Risk::Risk Factors [Medical Subject Headings]

Lesión renal aguda
lcsh:Chemistry
Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]
0302 clinical medicine
Risk Factors
Chronic kidney disease
Epidemiology
Organisms::Eukaryota::Animals [Medical Subject Headings]
Insuficiencia renal crónica
Receptor
lcsh:QH301-705.5
Spectroscopy
Diseases::Male Urogenital Diseases::Urologic Diseases::Kidney Diseases::Renal Insufficiency::Renal Insufficiency
Chronic [Medical Subject Headings]

Toll-Like Receptors
Acute kidney injury
Drugs
General Medicine
Acute Kidney Injury
female genital diseases and pregnancy complications
Computer Science Applications
Renal Replacement Therapy
Terapia
030220 oncology & carcinogenesis
Disease Progression
Medicamentos
Persons::Persons::Patients::Survivors [Medical Subject Headings]
medicine.symptom
Factores de riesgo
medicine.medical_specialty
Medicina
Receptores toll-like
Inflammation
Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Inflammatory Agents [Medical Subject Headings]
Catalysis
Analytical
Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Renal Replacement Therapy [Medical Subject Headings]

Inorganic Chemistry
03 medical and health sciences
Anthropology
Education
Sociology and Social Phenomena::Social Sciences::Internationality::International Cooperation::Developing Countries [Medical Subject Headings]

medicine
Animals
Humans
Renal replacement therapy
Physical and Theoretical Chemistry
Renal Insufficiency
Chronic

Molecular Biology
Pathological
Diseases::Cardiovascular Diseases [Medical Subject Headings]
therapy
Inflamación
Diseases::Pathological Conditions
Signs and Symptoms::Pathologic Processes::Disease Attributes::Disease Progression [Medical Subject Headings]

business.industry
urogenital system
Organic Chemistry
and therapy
medicine.disease
Toll-like receptors
Toll-Like Receptor 4
030104 developmental biology
lcsh:Biology (General)
lcsh:QD1-999
Risk factors
inflammation
TLR4
Chemicals and Drugs::Amino Acids
Peptides
and Proteins::Proteins::Membrane Proteins::Receptors
Cell Surface::Receptors
Immunologic::Receptors
Pattern Recognition::Toll-Like Receptors [Medical Subject Headings]

Therapy
business
Diseases::Pathological Conditions
Signs and Symptoms::Pathologic Processes::Inflammation [Medical Subject Headings]

Kidney disease
Zdroj: Biblos-e Archivo. Repositorio Institucional de la UAM
instname
International Journal of Molecular Sciences
International Journal of Molecular Science 22(2), 816 (2021)
Helvia: Repositorio Institucional de la Universidad de Córdoba
Universidad de Córdoba
Repisalud
Instituto de Salud Carlos III (ISCIII)
International Journal of Molecular Sciences, Vol 22, Iss 816, p 816 (2021)
Helvia. Repositorio Institucional de la Universidad de Córdoba
Universidad de Cantabria (UC)
Popis: Acute kidney injury (AKI) is an important health problem, affecting 13.3 million individuals/year. It is associated with increased mortality, mainly in low- and middle-income countries, where renal replacement therapy is limited. Moreover, survivors show adverse long-term outcomes, including increased risk of developing recurrent AKI bouts, cardiovascular events, and chronic kidney disease. However, there are no specific treatments to decrease the adverse consequences of AKI. Epidemiological and preclinical studies show the pathological role of inflammation in AKI, not only at the acute phase but also in the progression to chronic kidney disease. Toll-like receptors (TLRs) are key regulators of the inflammatory response and have been associated to many cellular processes activated during AKI. For that reason, a number of anti-inflammatory agents targeting TLRs have been analyzed in preclinical studies to decrease renal damage during AKI. In this review, we updated recent knowledge about the role of TLRs, mainly TLR4, in the initiation and development of AKI as well as novel compounds targeting these molecules to diminish kidney injury associated to this pathological condition
The authors work has been supported by grants from Instituto de Salud Carlos III (ISCIII, FIS-FEDER PI17/00130, PI17/01495, PI20/00375, PI20/00487), Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM) and Cardiovascular (CIBERCV), Spanish Ministry of Science and Innovation (RTI2018-099114-B-100, RTI2018-098788-B-100, DTS19/00093, RYC-2017-22369), and Spanish Societies of Cardiology (SEC), Nephrology (SEN) and Atherosclerosis (SEA). The “PFIS” and “Sara Borrell” training program of the ISCIII supported the salary of MGH (FI18/00310), SR-M (CD19/00021) and CH-B (CP16/00017). Córdoba University supported the salary of C.G.C.
Databáze: OpenAIRE